AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2016
Jun 3, 2016
29755_dirs_2016-06-03_969bfae0-1e23-4c62-b287-153a459ff697.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-06-02
Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-02 | Common stock, $0.01 par value | A | 285953 | $35.88 | Acquired | 624374 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 600 | $63.815 | Disposed | 623774 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 190468 | $63.8 | Disposed | 433306 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 7261 | $63.82 | Disposed | 426045 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1100 | $63.865 | Disposed | 424945 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 5402 | $63.9 | Disposed | 419543 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 300 | $63.8075 | Disposed | 419243 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1700 | $63.895 | Disposed | 417543 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 9434 | $63.81 | Disposed | 408109 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 13019 | $63.89 | Disposed | 395090 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 5397 | $63.83 | Disposed | 389693 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 400 | $63.875 | Disposed | 389293 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1000 | $63.93 | Disposed | 388293 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1511 | $63.85 | Disposed | 386782 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 400 | $63.835 | Disposed | 386382 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 2900 | $63.885 | Disposed | 383482 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 11726 | $63.88 | Disposed | 371756 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 4900 | $63.805 | Disposed | 366856 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1300 | $63.845 | Disposed | 365556 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 4300 | $63.86 | Disposed | 361256 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 4400 | $63.91 | Disposed | 356856 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 600 | $63.925 | Disposed | 356256 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 5699 | $63.87 | Disposed | 350557 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 2019 | $63.92 | Disposed | 348538 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 700 | $63.905 | Disposed | 347838 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 7717 | $63.84 | Disposed | 340121 | Direct |
| 2016-06-02 | Common stock, $0.01 par value | S | 1700 | $63.915 | Disposed | 338421 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-02 | Option(right to buy) | $35.88 | M | 285953 | Disposed | 2023-02-13 | Common stock (285953) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 4600 | Indirect |
| Common stock, $0.01 par value | 450 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these securities.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4